Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma

Metabolomic indicators of asthma treatment responses have yet to be identified. In this study, we aimed to uncover plasma metabolomic profiles associated with asthma exacerbations while on inhaled corticosteroid (ICS) treatment. We determined whether these profiles change with age from adolescence t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Priyadarshini Kachroo, Joanne E. Sordillo, Sharon M. Lutz, Scott T. Weiss, Rachel S. Kelly, Michael J. McGeachie, Ann Chen Wu, Jessica A. Lasky-Su
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	asthma inhaled corticosteroids metabolites metabolomics age interactions Medicine R
Acceso en línea:	https://doaj.org/article/26fbc14b80e54e5c81d0ae90845ef7c7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:26fbc14b80e54e5c81d0ae90845ef7c7
record_format	dspace
spelling	oai:doaj.org-article:26fbc14b80e54e5c81d0ae90845ef7c72021-11-25T18:07:33ZPharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma10.3390/jpm111111482075-4426https://doaj.org/article/26fbc14b80e54e5c81d0ae90845ef7c72021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4426/11/11/1148https://doaj.org/toc/2075-4426Metabolomic indicators of asthma treatment responses have yet to be identified. In this study, we aimed to uncover plasma metabolomic profiles associated with asthma exacerbations while on inhaled corticosteroid (ICS) treatment. We determined whether these profiles change with age from adolescence to adulthood. We utilized data from 170 individuals with asthma on ICS from the Mass General Brigham Biobank to identify plasma metabolites associated with asthma exacerbations while on ICS and examined potential effect modification of metabolite-exacerbation associations by age. We used liquid chromatography–high-resolution mass spectrometry-based metabolomic profiling. Sex-stratified analyses were also performed for the significant associations. The age range of the participating individuals was 13–43 years with a mean age of 33.5 years. Of the 783 endogenous metabolites tested, eight demonstrated significant associations with exacerbation after correction for multiple comparisons and adjusting for potential confounders (Bonferroni <i>p</i> value < 6.2 × 10<sup>−4</sup>). Potential effect modification by sex was detected for fatty acid metabolites, with males showing a greater reduction in their metabolite levels with ICS exacerbation. Thirty-eight metabolites showed suggestive interactions with age on exacerbation (nominal <i>p</i>-value < 0.05). Our findings demonstrate that plasma metabolomic profiles differ for individuals who experience asthma exacerbations while on ICS. The differentiating metabolites may serve as biomarkers of ICS response and may highlight metabolic pathways underlying ICS response variability.Priyadarshini KachrooJoanne E. SordilloSharon M. LutzScott T. WeissRachel S. KellyMichael J. McGeachieAnn Chen WuJessica A. Lasky-SuMDPI AGarticleasthmainhaled corticosteroidsmetabolitesmetabolomicsage interactionsMedicineRENJournal of Personalized Medicine, Vol 11, Iss 1148, p 1148 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	asthma inhaled corticosteroids metabolites metabolomics age interactions Medicine R
spellingShingle	asthma inhaled corticosteroids metabolites metabolomics age interactions Medicine R Priyadarshini Kachroo Joanne E. Sordillo Sharon M. Lutz Scott T. Weiss Rachel S. Kelly Michael J. McGeachie Ann Chen Wu Jessica A. Lasky-Su Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
description	Metabolomic indicators of asthma treatment responses have yet to be identified. In this study, we aimed to uncover plasma metabolomic profiles associated with asthma exacerbations while on inhaled corticosteroid (ICS) treatment. We determined whether these profiles change with age from adolescence to adulthood. We utilized data from 170 individuals with asthma on ICS from the Mass General Brigham Biobank to identify plasma metabolites associated with asthma exacerbations while on ICS and examined potential effect modification of metabolite-exacerbation associations by age. We used liquid chromatography–high-resolution mass spectrometry-based metabolomic profiling. Sex-stratified analyses were also performed for the significant associations. The age range of the participating individuals was 13–43 years with a mean age of 33.5 years. Of the 783 endogenous metabolites tested, eight demonstrated significant associations with exacerbation after correction for multiple comparisons and adjusting for potential confounders (Bonferroni <i>p</i> value < 6.2 × 10<sup>−4</sup>). Potential effect modification by sex was detected for fatty acid metabolites, with males showing a greater reduction in their metabolite levels with ICS exacerbation. Thirty-eight metabolites showed suggestive interactions with age on exacerbation (nominal <i>p</i>-value < 0.05). Our findings demonstrate that plasma metabolomic profiles differ for individuals who experience asthma exacerbations while on ICS. The differentiating metabolites may serve as biomarkers of ICS response and may highlight metabolic pathways underlying ICS response variability.
format	article
author	Priyadarshini Kachroo Joanne E. Sordillo Sharon M. Lutz Scott T. Weiss Rachel S. Kelly Michael J. McGeachie Ann Chen Wu Jessica A. Lasky-Su
author_facet	Priyadarshini Kachroo Joanne E. Sordillo Sharon M. Lutz Scott T. Weiss Rachel S. Kelly Michael J. McGeachie Ann Chen Wu Jessica A. Lasky-Su
author_sort	Priyadarshini Kachroo
title	Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
title_short	Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
title_full	Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
title_fullStr	Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
title_full_unstemmed	Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
title_sort	pharmaco-metabolomics of inhaled corticosteroid response in individuals with asthma
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/26fbc14b80e54e5c81d0ae90845ef7c7
work_keys_str_mv	AT priyadarshinikachroo pharmacometabolomicsofinhaledcorticosteroidresponseinindividualswithasthma AT joanneesordillo pharmacometabolomicsofinhaledcorticosteroidresponseinindividualswithasthma AT sharonmlutz pharmacometabolomicsofinhaledcorticosteroidresponseinindividualswithasthma AT scotttweiss pharmacometabolomicsofinhaledcorticosteroidresponseinindividualswithasthma AT rachelskelly pharmacometabolomicsofinhaledcorticosteroidresponseinindividualswithasthma AT michaeljmcgeachie pharmacometabolomicsofinhaledcorticosteroidresponseinindividualswithasthma AT annchenwu pharmacometabolomicsofinhaledcorticosteroidresponseinindividualswithasthma AT jessicaalaskysu pharmacometabolomicsofinhaledcorticosteroidresponseinindividualswithasthma
_version_	1718411606778445824

Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma

Ejemplares similares